✦ LIBER ✦

Abstract: 520 PHARMACOGENOMIC APPLICATION OF THE HAPTOGLOBIN GENOTYPE IN THE PREVENTION OF DIABETIC CARDIOVASCULAR DISEASE

✍ Scribed by Levy, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Application of pharmacogenomics in the p

✍ Andrew P. Levy 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 692 KB

ADVANCE in the Prevention of Cardiovascu

✍ Giuseppe Mancia 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 41 KB

Haptoglobin genotype and cardiovascular

✍ Moshe Vardi; Shany Blum; Andrew P. Levy 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 461 KB

The effect of interventions to prevent c

✍ Elbert S Huang; James B Meigs; Daniel E Singer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 86 KB

The clinical reality of guidelines for p

✍ O. Vaccaro; M. Boemi; F. Cavalot; P. De Feo; R. Miccoli; L. Patti; A.A. Rivelles 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 368 KB

Prevention of Cardiovascular Disease in

✍ David C. Goff Jr.; Hertzel C. Gerstein; Henry N. Ginsberg; William C. Cushman; K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 212 KB